← Leaderboards
Mamoru None Shoji
Emory University
$425,889
Attributed
$611,308
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $202.3K · FY2011–12$250K$187.5K$125K$62.5K$0
'11
'12
Funding mix
By agency
NIH$611,308 · 2
By mechanism
R21$611,308 · 2
Top collaborators
- Daniel J Brat2 shared
Most similar at Emory University
Same institution · by research overlap
- Haian Fu$16,783,892
- Keith D Wilkinson$9,482,314
- Ifor R Williams$2,980,545
- Matam Vijay-Kumar$4,492,689
- Walter H Watson$1,726,188
Others in their field
Top investigators on “Vascular Endothelial Growth Factors”
- Keri Hammel · The Emmes Company, Llc$41,089,609
- Michael Simons · Yale University$37,207,792
- Norman Wolmark · Nsabp Foundation, Inc.$27,593,122
- Shahin Rafii · Weill Medical College Of Cornell Univ$24,406,332
- Rakesh K. Jain · Massachusetts General Hospital$23,479,897
- Aleksander S. Popel · Johns Hopkins University$19,039,579
Research focus
Vascular Endothelial Growth FactorsThromboplastinReceptor Mediated EndocytosisAnalogApoptosisArginineAngiogenesisBinding (Molecular Function)AntineoplasticsBlood - Brain Barrier AnatomyBlood VesselsBrainBrain NeoplasmsCaspase-3CellsAthymic MouseCell Cycle ArrestCell Surface ReceptorsChemical ConjugateChemical SynthesisCoagulation Factor ViiCrohn&AposCurcuminCaspase-8
Grant awards (4)
Targeted Delivery of a Novel Synthetic Curcumin Analog, EF24 to Glioblastoma and$202,275
R21 · FY2012 · CA · contact PI
Targeted Delivery of a Novel Synthetic Curcumin Analog, EF24 to Glioblastoma and$168,563
R21 · FY2011 · CA · contact PI
INHIBITION OF TISSUE FACTOR MEDIATED ANGIOGENESIS$121,800
R21 · FY2001 · CA
INHIBITION OF TISSUE FACTOR MEDIATED ANGIOGENESIS$118,670
R21 · FY2000 · CA